Medicine & Life Sciences
1,4-dihydropyridine
32%
1,4-dihydropyrimidine
29%
acetamide
19%
acrylic acid
18%
alpha-aminopyridine
24%
Amides
26%
Amines
43%
Amino Acids
24%
Aminopyridines
22%
Aminoquinolines
23%
aniline
18%
Ataxin-3
21%
Binding Sites
21%
Calcium Channel Blockers
20%
Casein Kinases
19%
Catalytic Domain
23%
Cheminformatics
20%
Cyclic Ethers
25%
Cyclization
19%
dibromoisocyanuric acid
31%
Drug Design
24%
Esters
26%
glutaminyl-peptide cyclotransferase
24%
Heme
26%
Janus Kinase 1
20%
L-Type Calcium Channels
78%
Ligands
22%
Machado-Joseph Disease
19%
mitoquinone
24%
NAD(P)H Dehydrogenase (Quinone)
18%
Necroptosis
18%
Nitric Oxide Synthase
80%
Nitric Oxide Synthase Type I
48%
Parkinson Disease
19%
phenyl ether
22%
Propionates
19%
Protein Isoforms
46%
Proteins
20%
Pyrans
42%
pyrazolo(3,4-d)pyrimidine
23%
pyrimidine-2,4,6-trione
29%
pyrrolo(2, 3-b)pyridine
26%
Quinolizines
26%
Resveratrol
22%
rubimaillin
27%
Static Electricity
22%
Structure-Activity Relationship
32%
titanium tetrachloride
25%
TNF Receptor-Associated Factor 1
21%
Tumor Necrosis Factor Receptors
22%
Chemical Compounds
4H-Pyran
20%
Acetamide
13%
Acid
18%
Acrylic Acid
11%
Amide
18%
Amine
20%
Aminopyridine
17%
Antagonist
24%
Anti-Inflammatory Agent
16%
Antimicrobial Agent
14%
Binding Site
23%
Calcium(0)
15%
Crystal Structure
21%
Cyclic Ether
24%
Cyclization Reaction
19%
Dantrolene
22%
Dihydropyridine
39%
Disorder
27%
Drug
22%
Enzyme Inhibitor
14%
Ester
16%
Heme
22%
Hsp90 Inhibitor
31%
Kd
15%
Kojic Acid
10%
Ligand
11%
Melanin
15%
Metabolic
26%
Microwave Irradiation
12%
Neurotransmitter
14%
Nitric Oxide
18%
Nitric Oxide Synthase Inhibitor
100%
Oxidative Stress
13%
Permeability
10%
Plasma
13%
Positron
14%
Primary Amine
14%
Propionate
17%
Protecting Group
12%
Protein
24%
Pterin
18%
Quinolizine
19%
Quinone
12%
Reaction Yield
16%
Resveratrol
24%
Ryanodine
18%
Stellate Crystal
20%
Structure-Activity Relationship
27%
Tyrosine Residue
14%
Urea
15%